8-K/A

FORM 8-K/A

Company: BIOCRYST PHARMACEUTICALS INC
Filed: September 4, 2018
Period of Report: September 4, 2018
Accession Number: 0001171843-18-006363

View Document ↗ View on SEC.gov ↗